Stem cell tracking with nanoparticles for regenerative medicine purposes: An overview

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Accomasso, Lisa ^a   Gallina, Clara ^a   Turinetto, Valentina ^a   Giachino, Claudia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; GOLD NANOPARTICLE; MESOPOROUS SILICA; NANOPARTICLE; POLY(3,4 ETHYLENEDIOXYTHIOPHENE); POLY(ARYLENEDIETHYNLENES); POLY(THIOPHENE 3 YL ACETIC ACID); POLYACETYLENE; POLYCAPROLACTONE; POLYSTYRENE; QUANTUM DOT; SILICA NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; BIOSAFETY; CARDIAC STEM CELL; CELL LABELING; CELL TRACKING; CENTRAL NERVOUS SYSTEM CELL; CORD BLOOD NUCLEATED CELL; EMBRYONIC STEM CELL; FLUORESCENCE; FLUORESCENCE IMAGING; GENETIC MANIPULATION; HUMAN; IN VIVO STUDY; MESENCHYMAL STEM CELL; NANOTOXICOLOGY; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOACOUSTICS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL;

EID: 84956912957     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/7920358     Document Type: Review

References (248)

1. A. S. Daar, P. A. Singer, D. L. Persad et al., "Grand challenges in chronic non-communicable diseases, " Nature, vol. 450, no. 7169, pp. 494-496, 2007.
2. D. J. Laird, U. H. von Andrian, and A. J. Wagers, "Stem cell trafficking in tissue development, growth, and disease, " Cell, vol. 132, no. 4, pp. 612-630, 2008.
3. J. M. Gimble, A. J. Katz, and B. A. Bunnell, "Adipose-derived stem cells for regenerative medicine, " Circulation Research, vol. 100, no. 9, pp. 1249-1260, 2007.
4. M. J. Evans and M. H. Kaufman, "Establishment in culture of pluripotential cells from mouse embryos, " Nature, vol. 292, no. 5819, pp. 154-156, 1981.
5. G. R. Martin, "Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 12, pp. 7634-7638, 1981.
6. F. M. Kamm, "Ethical issues in using and not using embryonic stem cells, " Stem Cell Reviews, vol. 1, no. 4, pp. 325-330, 2005.
7. I. Hyun, "The bioethics of stem cell research and therapy, " Journal of Clinical Investigation, vol. 120, no. 1, pp. 71-75, 2010.
8. K. Takahashi and S. Yamanaka, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, " Cell, vol. 126, no. 4, pp. 663-676, 2006.
9. K. Takahashi, K. Tanabe, M. Ohnuki et al., "Induction of pluripotent stem cells from adult human fibroblasts by defined factors, " Cell, vol. 131, no. 5, pp. 861-872, 2007.
10. K. Okita, T. Ichisaka, and S. Yamanaka, "Generation of germline-competent induced pluripotent stem cells, " Nature, vol. 448, no. 7151, pp. 313-317, 2007.
11. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., "Induced pluripotent stem cell lines derived from human somatic cells, " Science, vol. 318, no. 5858, pp. 1917-1920, 2007.
12. D. J. Wong, H. Liu, T. W. Ridky, D. Cassarino, E. Segal, and H. Y. Chang, "Module map of stem cell genes guides creation of epithelial cancer stem cells, " Cell Stem Cell, vol. 2, no. 4, pp. 333-344, 2008.
13. K. Miura, Y. Okada, T. Aoi et al., "Variation in the safety of induced pluripotent stem cell lines, " Nature Biotechnology, vol. 27, no. 8, pp. 743-745, 2009.
14. J. J. Cunningham, T. M. Ulbright, M. F. Pera, and L. H. J. Looijenga, "Lessons fromhuman teratomas to guide development of safe stem cell therapies, " Nature Biotechnology, vol. 30, no. 9, pp. 849-857, 2012.
15. D. W. Fink, "FDA regulation of stem cell-based products, " Science, vol. 324, no. 5935, pp. 1662-1663, 2009.
16. I. Gutierrez-Aranda, V. Ramos-Mejia, C. Bueno et al., "Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection, " Stem Cells, vol. 28, no. 9, pp. 1568-1570, 2010.
17. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., "Pluripotency ofmesenchymal stemcells derived from adultmarrow, " Nature, vol. 418, no. 6893, pp. 41-49, 2002.
18. P. J. Quesenberry, L. R. Goldberg, and M. S. Dooner, "Concise reviews: a stemcell apostasy: a tale of fourHwords, " Stem Cells, vol. 33, no. 1, pp. 15-20, 2014.
19. D. A. Lim and A. Alvarez-Buylla, "Adult neural stem cells stake their ground, " Trends in Neurosciences, vol. 37, no. 10, pp. 563-571, 2014.
20. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
21. P. A. Zuk, M. Zhu, P. Ashjian et al., "Human adipose tissue is a source of multipotent stem cells, " Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279-4295, 2002.
22. F. Marongiu, R. Gramignoli, Q. Sun et al., "Isolation of amniotic mesenchymal stem cells, " Current Protocols in Stem Cell Biology, vol. 1, pp. 1E.5.1-1E.5.11, 2010.
23. E. J. Gang, J. A. Jeong, S. H. Hong et al., "Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood, " STEM CELLS, vol. 22, no. 4, pp. 617-624, 2004.
24. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, "Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart, " Circulation, vol. 105, no. 1, pp. 93-98, 2002.
25. F. P. Jori, M. A. Napolitano, M. A. B. Melone et al., "Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells, " Journal of Cellular Biochemistry, vol. 94, no. 4, pp. 645-655, 2005.
26. L. C. Amado, A. P. Saliaris, K. H. Schuleri et al., "Cardiac repair with intramyocardial injection of allogeneicmesenchymal stem cells after myocardial infarction, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11474-11479, 2005.
27. Y. Miyahara, N. Nagaya, M. Kataoka et al., "Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction, " Nature Medicine, vol. 12, no. 4, pp. 459-465, 2006.
28. D. J. Prockop, M. Brenner, W. E. Fibbe et al., "Defining the risks of mesenchymal stromal cell therapy, " Cytotherapy, vol. 12, no. 5, pp. 576-578, 2010.
29. A. I. Caplan, "Adultmesenchymal stem cells for tissue engineering versus regenerative medicine, " Journal of Cellular Physiology, vol. 213, no. 2, pp. 341-347, 2007.
30. J. M. Ryan, F. P. Barry, J. M. Murphy, and B. P. Mahon, "Mesenchymal stem cells avoid allogeneic rejection, " Journal of Inflammation, vol. 2, no. 1, article 8, 2005.
31. A. Saparov, C.-W. Chen, S. A. Beckman, Y. Wang, and J. Huard, "The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair, " International Journal of Molecular Sciences, vol. 14, no. 8, pp. 16258-16279, 2013.
32. H. Skalnikova, J. Motlik, S. J. Gadher, and H. Kovarova, "Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines, " Proteomics, vol. 11, no. 4, pp. 691-708, 2011.
33. C. Gallina, V. Turinetto, and C. Giachino, "A new paradigm in cardiac regeneration: the mesenchymal stem cell secretome, " Stem Cells International, vol. 2015, Article ID 765846, 10 pages, 2015.
34. M. P. Lutolf and J. A. Hubbell, "Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering, " Nature Biotechnology, vol. 23, no. 1, pp. 47-55, 2005.
35. J. E. Dennis, S. E. Haynesworth, R. G. Young, and A. I. Caplan, "Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression, " Cell Transplantation, vol. 1, no. 1, pp. 23-32, 1992.
36. J. E. Dennis, E. K. Konstantakos, D. Arm, and A. I. Caplan, "In vivo osteogenesis assay: a rapid method for quantitative analysis, " Biomaterials, vol. 19, no. 15, pp. 1323-1328, 1998.
37. H. Ohgushi and A. I. Caplan, "Stem cell technology and bioceramics: from cell to gene engineering, " Journal of Biomedical Materials Research, vol. 48, no. 6, pp. 913-927, 1999.
38. L. A. Solchaga, J. S. Temenoff, J. Gao, A. G. Mikos, A. I. Caplan, and V. M. Goldberg, "Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds, " Osteoarthritis and Cartilage, vol. 13, no. 4, pp. 297-309, 2005.
39. H. Ohgushi, Y. Dohi, S. Tamai, and S. Tabata, "Osteogenic differentiation ofmarrowstromal stem cells in porous hydroxyapatite ceramics, " Journal of Biomedical Materials Research, vol. 27, no. 11, pp. 1401-1407, 1993.
40. H. Ohgushi, N. Kotobuki, H. Funaoka et al., "Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis, " Biomaterials, vol. 26, no. 22, pp. 4654-4661, 2005.
41. C. Cristallini, E. Cibrario Rocchietti, L. Accomasso et al., "The effect of bioartificial constructs that mimic myocardial structure and biomechanical properties on stem cell commitment towards cardiac lineage, " Biomaterials, vol. 35, no. 1, pp. 92-104, 2014.
42. K. R. Kirker, Y. Luo, J. H. Nielson, J. Shelby, and G. D. Prestwich, "Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing, " Biomaterials, vol. 23, no. 17, pp. 3661-3671, 2002.
43. H. Park, J. S. Temenoff, Y. Tabata, A. I. Caplan, and A. G. Mikos, "Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering, " Biomaterials, vol. 28, no. 21, pp. 3217-3227, 2007.
44. G. Ren, X. Chen, F. Dong et al., "Concise review: mesenchymal stem cells and translational medicine: emerging issues, " Stem Cells Translational Medicine, vol. 1, no. 1, pp. 51-58, 2012.
45. P. K. Nguyen, D. Nag, and J. C. Wu, "Methods to assess stem cell lineage, fate and function, "AdvancedDrugDelivery Reviews, vol. 62, no. 12, pp. 1175-1186, 2010.
46. M. Srinivas, E. H. J. G. Aarntzen, J. W. M. Bulte et al., "Imaging of cellular therapies, " Advanced Drug Delivery Reviews, vol. 62, no. 11, pp. 1080-1093, 2010.
47. L. Otero, M. Zurita, C. Bonilla et al., "Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates endogenous neurogenesis, " Cytotherapy, vol. 14, no. 1, pp. 34-44, 2012.
48. J. K. Lee, H. K. Jin, S. Endo, E. H. Schuchman, J. E. Carter, and J.-S. Bae, "Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimers disease mice by modulation of immune responses, " Stem Cells, vol. 28, no. 2, pp. 329-343, 2010.
49. F. D. Pagani, H. DerSimonian, A. Zawadzka et al., "Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation, " Journal of the American College of Cardiology, vol. 41, no. 5, pp. 879-888, 2003.
50. M. Peran, M. A. Garcia, E. Lopez-Ruiz et al., "Functionalized nanostructures with application in regenerative medicine, " International Journal of Molecular Sciences, vol. 13, no. 3, pp. 3847-3886, 2012.
51. D. G. Buschke, J. M. Squirrell, J. J. Fong, K. W. Eliceiri, and B. M. Ogle, "Cell death, non-invasively assessed by intrinsic fluorescence intensity of NADH, is a predictive indicator of functional differentiation of embryonic stem cells, " Biology of the Cell, vol. 104, no. 6, pp. 352-364, 2012.
52. M. Chalfie, Y. Tu, G. Euskirchen, W. W. Ward, and D. C. Prasher, "Green fluorescent protein as a marker for gene expression, " Science, vol. 263, no. 5148, pp. 802-805, 1994.
53. H. Wang, F. Cao, A. De et al., "Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging, " Stem Cells, vol. 27, no. 7, pp. 1548-1558, 2009.
54. A. Bhirde, J. Xie, M. Swierczewska, and X. Chen, "Nanoparticles for cell labeling, " Nanoscale, vol. 3, no. 1, pp. 142-153, 2011.
55. A. Solanki, J. D. Kim, and K.-B. Lee, "Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging, " Nanomedicine, vol. 3, no. 4, pp. 567-578, 2008.
56. K. D. Deb, M. Griffith, E. de Muinck, and M. Rafat, "Nanotechnology in stem cells research: advances and applications, " Frontiers in Bioscience, vol. 17, no. 5, pp. 1747-1760, 2012.
57. C. Villa, S. Erratico, P. Razini et al., "Stem cell tracking by nanotechnologies, " International Journal of Molecular Sciences, vol. 11, no. 3, pp. 1070-1081, 2010.
58. K. Donaldson, "Resolving the nanoparticles paradox, " Nanomedicine, vol. 1, no. 2, pp. 229-234, 2006.
59. S. Arora, J. M. Rajwade, and K. M. Paknikar, "Nanotoxicology and in vitro studies: the need of the hour, " Toxicology and Applied Pharmacology, vol. 258, no. 2, pp. 151-165, 2012.
60. European Commission, "Commission recommendation of 18 October 2011 on the definition of nanomaterial (2011/696/EU), " Official Journal of the European Communities: Legis, pp. 275-238, 2011.
61. D. Napierska, L. C. J. Thomassen, D. Lison, J. A. Martens, and P. H. Hoet, "The nanosilica hazard: another variable entity, " Particle and Fibre Toxicology, vol. 7, no. 1, article 39, 2010.
62. T. Linsinger, G. Roebben, D. Gilliland et al., Requirements on Measurements for the Implementation of the European Commission Definition of the Termnanomaterial, Publications Office of the European Union, 2012.
63. N. V. Long, N. D. Chien, T. Hayakawa, H. Hirata, G. Lakshminarayana, and M. Nogami, "The synthesis and characterization of platinum nanoparticles: a method of controlling the size and morphology, " Nanotechnology, vol. 21, no. 3, Article ID035605, 2010.
64. J. Ahmed, S. Sharma, K. V. Ramanujachary, S. E. Lofland, and A. K. Ganguli, "Microemulsion-mediated synthesis of cobalt (pure fcc and hexagonal phases) and cobalt-nickel alloy nanoparticles, " Journal of Colloid and Interface Science, vol. 336, no. 2, pp. 814-819, 2009.
65. J.-S. Hu, Y.-G. Guo, H.-P. Liang, L.-J. Wan, and L. Jiang, "Three-dimensional self-organization of supramolecular selfassembled porphyrin hollow hexagonal nanoprisms, " Journal of the American Chemical Society, vol. 127, no. 48, pp. 17090-17095, 2005.
66. M. Jitianu and D. V. Goia, "Zinc oxide colloids with controlled size, shape, and structure, " Journal of Colloid and Interface Science, vol. 309, no. 1, pp. 78-85, 2007.
67. T.-Z. Ren, Z.-Y. Yuan, W. Hu, and X. Zou, "Single crystal manganese oxide hexagonal plates with regulated mesoporous structures, "Microporous andMesoporousMaterials, vol. 112, no. 1-3, pp. 467-473, 2008.
68. E. Schmidt, A. Vargas, T. Mallat, and A. Baiker, "Shape-selective enantioselective hydrogenation on Pt nanoparticles, " Journal of the American Chemical Society, vol. 131, no. 34, pp. 12358-12367, 2009.
69. N. R. Jana, L. Gearheart, and C. J. Murphy, "Seed-mediated growth approach for shape-controlled synthesis of spheroidal and rod-like gold nanoparticles using a surfactant template, " Advanced Materials, vol. 13, no. 18, pp. 1389-1393, 2001.
70. L. Guo, Y. Ji, H. Xu, Z. Wu, and P. Simon, "Synthesis and evolution of rod-like nano-scaled ZnC2O4·2H2O whiskers to ZnO nanoparticles, " Journal of Materials Chemistry, vol. 13, no. 4, pp. 754-757, 2003.
71. R. Xiao, S. I. Cho, R. Liu, and B. L. Sang, "Controlled electrochemical synthesis of conductive polymer nanotube structures, " Journal of the American Chemical Society, vol. 129, no. 14, pp. 4483-4489, 2007.
72. G. Oberdorster, E. Oberdorster, and J. Oberdorster, "Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles, " Environmental Health Perspectives, vol. 113, no. 7, pp. 823-839, 2005.
73. F. Joris, B. B. Manshian, K. Peynshaert, S. C. De Smedt, K. Braeckmans, and S. J. Soenen, "Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap, " Chemical Society Reviews, vol. 42, no. 21, pp. 8339-8359, 2013.
74. C. M. Sayes and D. B. Warheit, "Characterization of nanomaterials for toxicity assessment, " Wiley Interdisciplinary Reviews: Nanomedicine andNanobiotechnology, vol. 1, no. 6, pp. 660-670, 2009.
75. D. Walczyk, F. B. Bombelli, M. P. Monopoli, I. Lynch, and K. A. Dawson, "What the cell "sees" in bionanoscience, " Journal of the American Chemical Society, vol. 132, no. 16, pp. 5761-5768, 2010.
76. M. P. Monopoli, C. Aberg, A. Salvati, and K. A. Dawson, "Biomolecular coronas provide the biological identity of nanosized materials, " Nature Nanotechnology, vol. 7, no. 12, pp. 779-786, 2012.
77. A. S. Pitek, D. O'Connell, E. Mahon, M. P. Monopoli, F. Francesca Baldelli, and K. A. Dawson, "Transferrin coated nanoparticles: study of the bionano interface in human plasma, " PLoS ONE, vol. 7, no. 7, Article ID e40685, 2012.
78. P. M. Kelly, C. Aberg, E. Polo et al., "Mapping protein binding sites on the biomolecular corona of nanoparticles, " Nature Nanotechnology, vol. 10, no. 5, pp. 472-479, 2015.
79. S. Wan, P. M. Kelly, E. Mahon et al., "The Sweet side of the protein corona: effects of glycosylation on nanoparticle-cell interactions, " ACS Nano, vol. 9, no. 2, pp. 2157-2166, 2015.
80. S. Tenzer, D. Docter, J. Kuharev et al., "Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology, " Nature Nanotechnology, vol. 8, no. 10, pp. 772-781, 2013.
81. E. Casals, T. Pfaller, A. Duschl, G. J. Oostingh, and V. F. Puntes, "Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles, " Small, vol. 7, no. 24, pp. 3479-3486, 2011.
82. G. Maiorano, S. Sabella, B. Sorce et al., "Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response, " ACS Nano, vol. 4, no. 12, pp. 7481-7491, 2010.
83. Y. Gao, Y. Cui, J. K. Chan, and C. Xu, "Stem cell tracking with optically active nanoparticles, " American Journal of Nuclear Medicine andMolecular Imaging, vol. 3, no. 3, pp. 232-246, 2013.
84. S. Lehmann, S. Seiffert, and W. Richtering, "Diffusion of guest moleculeswithin sensitive core-shell microgel carriers, " Journal of Colloid and Interface Science, vol. 431, pp. 204-208, 2014.
85. D. Shcharbin, A. Shakhbazau, and M. Bryszewska, "Poly(amidoamine) dendrimer complexes as a platformfor gene delivery, " Expert Opinion on Drug Delivery, vol. 10, no. 12, pp. 1687-1698, 2013.
86. E. Perez-Herrero and A. Fernandez-Medarde, "Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy, " European Journal of Pharmaceutics and Biopharmaceutics, vol. 93, pp. 52-79, 2015.
87. J. L. Arias, "Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging, " Expert Opinion on Drug Delivery, vol. 8, no. 12, pp. 1589-1608, 2011.
88. M. Liong, J. Lu, M. Kovochich et al., "Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery, " ACS Nano, vol. 2, no. 5, pp. 889-896, 2008.
89. E. L. da Rocha, L. M. Porto, and C. R. Rambo, "Nanotechnology meets 3D in vitro models: tissue engineered tumors and cancer therapies, " Materials Science and Engineering: C, vol. 34, no. 1, pp. 270-279, 2014.
90. S. Jung, J. Nam, S. Hwang et al., "TheragnosticpH-sensitive gold nanoparticles for the selective surface enhanced Raman scattering and photothermal cancer therapy, " Analytical Chemistry, vol. 85, no. 16, pp. 7674-7681, 2013.
91. M. M. Shenoi, N. B. Shah, R. J. Griffin, G. M. Vercellotti, and J. C. Bischof, "Nanoparticle preconditioning for enhanced thermal therapies in cancer, " Nanomedicine, vol. 6, no. 3, pp. 545-563, 2011.
92. K. Donaldson, V. Stone, C. L. Tran, W. Kreyling, and P. J. A. Borm, "Nanotoxicology, " Occupational and Environmental Medicine, vol. 61, no. 9, pp. 727-728, 2004.
93. N. Lewinski, V. Colvin, and R. Drezek, "Cytotoxicity of nanopartides, " Small, vol. 4, no. 1, pp. 26-49, 2008.
94. A. Nel, T. Xia, L. Madler, and N. Li, "Toxic potential ofmaterials at the nanolevel, " Science, vol. 311, no. 5761, pp. 622-627, 2006.
95. R. Duffin, L. Tran, D. Brown, V. Stone, and K. Donaldson, "Proinflammogenic effects of low-toxicity andmetal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity, " Inhalation Toxicology, vol. 19, no. 10, pp. 849-856, 2007.
96. E. C. Cho, Q. Zhang, and Y. Xia, "The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles, " Nature Nanotechnology, vol. 6, no. 6, pp. 385-391, 2011.
97. T. Wang, J. Bai, X. Jiang, and G. U. Nienhaus, "Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry, " ACS Nano, vol. 6, no. 2, pp. 1251-1259, 2012.
98. C. Schweiger, R. Hartmann, F. Zhang, W. J. Parak, T. H. Kissel, and P. Rivera-Gil, "Quantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite charge, " Journal of Nanobiotechnology, vol. 10, no. 1, article 28, 2012.
99. A. K. Gupta, M. Gupta, S. J. Yarwood, and A. S. G. Curtis, "Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts, " Journal of Controlled Release, vol. 95, no. 2, pp. 197-207, 2004.
100. Y. Yang, C. Bauer, G. Strasser, R. Wollman, J.-P. Julien, and E. Fuchs, "Integrators of the cytoskeleton that stabilize microtubules, " Cell, vol. 98, no. 2, pp. 229-238, 1999.
101. B. Qualmann, M. M. Kessels, and R. B. Kelly, "Molecular links between endocytosis and the actin cytoskeleton, " The Journal of Cell Biology, vol. 150, no. 5, pp. F111-F116, 2000.
102. A. K. Gupta and M. Gupta, "Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles, " Biomaterials, vol. 26, no. 13, pp. 1565-1573, 2005.
103. C. C. Berry, S. Wells, S. Charles, G. Aitchison, and A. S. G. Curtis, "Cell response to dextran-derivatised iron oxide nanoparticles post internalisation, " Biomaterials, vol. 25, no. 23, pp. 5405-5413, 2004.
104. K. Buyukhatipoglu and A. M. Clyne, "Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation, " Journal of BiomedicalMaterials Research A, vol. 96, no. 1, pp. 186-195, 2011.
105. K. Donaldson, P. J. A. Borm, V. Castranova, and M. Gulumian, "The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles, " Particle and Fibre Toxicology, vol. 6, article 13, 2009.
106. L. Risom, P. Moller, and S. Loft, "Oxidative stress-induced DNA damage by particulate air pollution, " Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 592, no. 1-2, pp. 119-137, 2005.
107. Y.-J. Gu, J. Cheng, C.-C. Lin, Y. W. Lam, S. H. Cheng, and W.-T. Wong, "Nuclear penetration of surface functionalized gold nanoparticles, " Toxicology and Applied Pharmacology, vol. 237, no. 2, pp. 196-204, 2009.
108. N. Singh, B. Manshian, G. J. S. Jenkins et al., "NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials, " Biomaterials, vol. 30, no. 23-24, pp. 3891-3914, 2009.
109. T. R. Pisanic II, J. D. Blackwell, V. I. Shubayev, R. R. Finones, and S. Jin, "Nanotoxicity of iron oxide nanoparticle internalization in growing neurons, " Biomaterials, vol. 28, no. 16, pp. 2572-2581, 2007.
110. S. Lanone and J. Boczkowski, "Biomedical applications and potential health risks of nanomaterials: molecular mechanisms, " Current Molecular Medicine, vol. 6, no. 6, pp. 651-663, 2006.
111. A. El-Ansary and S. Al-Daihan, "On the toxicity of therapeutically used nanoparticles: an overview, " Journal of Toxicology, vol. 2009, Article ID754810, 9 pages, 2009.
112. K. L. Aillon, Y. Xie, N. El-Gendy, C. J. Berkland, and M. L. Forrest, "Effects of nanomaterial physicochemical properties on in vivo toxicity, " Advanced Drug Delivery Reviews, vol. 61, no. 6, pp. 457-466, 2009.
113. L. Ferreira, J. M. Karp, L. Nobre, and R. Langer, "New opportunities: the use of nanotechnologies to manipulate and track stem cells, " Cell Stem Cell, vol. 3, no. 2, pp. 136-146, 2008.
114. S. B. Rizvi, S. Ghaderi, M. Keshtgar, A. M. Seifalian, and M. Muhammed, "Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging, " Nano Reviews, vol. 1, 2010.
115. I. L. Medintz, H. T. Uyeda, E. R. Goldman, and H. Mattoussi, "Quantum dot bioconjugates for imaging, labelling and sensing, " Nature Materials, vol. 4, no. 6, pp. 435-446, 2005.
116. J. K. Jaiswal, H. Mattoussi, J. M. Mauro, and S. M. Simon, "Longterm multiple color imaging of live cells using quantum dot bioconjugates, " Nature Biotechnology, vol. 21, no. 1, pp. 47-51, 2002.
117. A. R. Clapp, I. L. Medintz, and H. Mattoussi, "Forster resonance energy transfer investigations using quantum-dot fluorophores, " ChemPhysChem, vol. 7, no. 1, pp. 47-57, 2006.
118. I. L. Medintz and H. Mattoussi, "Quantumdot-based resonance energy transfer and its growing application in biology, " Physical Chemistry Chemical Physics, vol. 11, no. 1, pp. 17-45, 2009.
119. W. C. W. Chan, D. J. Maxwell, X. Gao, R. E. Bailey, M. Han, and S. Nie, "Luminescent quantum dots for multiplexed biological detection and imaging, " Current Opinion in Biotechnology, vol. 13, no. 1, pp. 40-46, 2002.
120. M. Seydack, "Nanoparticle labels in immunosensing using optical detection methods, " Biosensors and Bioelectronics, vol. 20, no. 12, pp. 2454-2469, 2005.
121. Z. Deng, Y. Zhang, J. Yue, F. Tang, and Q. Wei, "Green and orange CdTe quantumdots as effective pH-sensitive fluorescent probes for dual simultaneous and independent detection of viruses, "The Journal of Physical Chemistry B, vol. 111, no. 41, pp. 12024-12031, 2007.
122. W. R. Algar and U. J. Krull, "Quantum dots as donors in fluorescence resonance energy transfer for the bioanalysis of nucleic acids, proteins, and other biological molecules, " Analytical and Bioanalytical Chemistry, vol. 391, no. 5, pp. 1609-1618, 2008.
123. X. Wu, H. Liu, J. Liu et al., "Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots, " Nature Biotechnology, vol. 21, no. 1, pp. 41-46, 2003.
124. M. K. Wagner, F. Li, J. Li, X.-F. Li, and X. C. Le, "Use of quantum dots in the development of assays for cancer biomarkers, " Analytical and Bioanalytical Chemistry, vol. 397, no. 8, pp. 3213-3224, 2010.
125. A. M. Derfus, W. C. W. Chan, and S. N. Bhatia, "Probing the cytotoxicity of semiconductor quantumdots, " Nano Letters, vol. 4, no. 1, pp. 11-18, 2004.
126. X. Michalet, F. F. Pinaud, L. A. Bentolila et al., "Quantum dots for live cells, in vivo imaging, and diagnostics, " Science, vol. 307, no. 5709, pp. 538-544, 2005.
127. X. Gao, L. Yang, J. A. Petros, F. F. Marshall, J. W. Simons, and S. Nie, "In vivo molecular and cellular imaging with quantum dots, " Current Opinion in Biotechnology, vol. 16, no. 1, pp. 63-72, 2005.
128. A. Hoshino, K. Fujioka, T. Oku et al., "Physicochemical properties and cellular toxicity of nanocrystal quantumdots depend on their surface modification, " Nano Letters, vol. 4, no. 11, pp. 2163-2169, 2004.
129. M. Bruchez Jr., M. Moronne, P. Gin, S. Weiss, and A. P. Alivisatos, "Semiconductor nanocrystals as fluorescent biological labels, " Science, vol. 281, no. 5385, pp. 2013-2016, 1998.
130. W. C. W. Chan and S. Nie, "Quantum dot bioconjugates for ultrasensitive nonisotopic detection, " Science, vol. 281, no. 5385, pp. 2016-2018, 1998.
131. S. K. Chakraborty, J. A. J. Fitzpatrick, J. A. Phillippi et al., "Cholera toxin B conjugated quantumdots for live cell labeling, " Nano Letters, vol. 7, no. 9, pp. 2618-2626, 2007.
132. B. S. Shah, P. A. Clark, E. K. Moioli, M. A. Stroscio, and J. J. Mao, "Labeling of mesenchymal stem cells by bioconjugated quantum dots, " Nano Letters, vol. 7, no. 10, pp. 3071-3079, 2007.
133. S.-C. Hsieh, F.-F. Wang, S.-C. Hung, Y.-J. Chen, and Y.-J. Wang, "The internalized CdSe/ZnS quantum dots impair the chondrogenesis of bone marrow mesenchymal stem cells, " Journal of BiomedicalMaterials Research BApplied Biomaterials, vol. 79, no. 1, pp. 95-101, 2006.
134. S.-C. Hsieh, F.-F. Wang, C.-S. Lin, Y.-J. Chen, S.-C. Hung, and Y.-J. Wang, "The inhibition of osteogenesis with human bone marrow mesenchymal stem cells by CdSe/ZnS quantum dot labels, " Biomaterials, vol. 27, no. 8, pp. 1656-1664, 2006.
135. B. Dubertret, P. Skourides, D. J. Norris, V. Noireaux, A. H. Brivanlou, and A. Libchaber, "In vivo imaging of quantum dots encapsulated in phospholipid micelles, " Science, vol. 298, no. 5599, pp. 1759-1762, 2002.
136. G. Wang, G. Zeng, C. Wang et al., "Biocompatibility of quantum dots (CdSe/ZnS ) in human amniotic membrane-derived mesenchymal stem cells in vitro, " Biomedical Papers, vol. 159, no. 2, pp. 227-233, 2015.
137. B. S. Shah and J. J. Mao, "Labeling of mesenchymal stem cells with bioconjugated quantum dots, " Methods in Molecular Biology, vol. 680, pp. 61-75, 2011.
138. G. Chen, F. Tian, C. Li et al., "In vivo real-time visualization of mesenchymal stem cells tropism for cutaneous regeneration using NIR-II fluorescence imaging, " Biomaterials, vol. 53, pp. 265-273, 2015.
139. L. Tang and J. Cheng, "Nonporous silica nanoparticles for nanomedicine application, " Nano Today, vol. 8, no. 3, pp. 290-312, 2013.
140. F. Tang, L. Li, and D. Chen, "Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery, " Advanced Materials, vol. 24, no. 12, pp. 1504-1534, 2012.
141. I. I. Slowing, J. L. Vivero-Escoto, C.-W. Wu, and V. S.-Y. Lin, "Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers, " Advanced Drug Delivery Reviews, vol. 60, no. 11, pp. 1278-1288, 2008.
142. M. Benezra, O. Penate-Medina, P. B. Zanzonico et al., "Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma, " The Journal of Clinical Investigation, vol. 121, no. 7, pp. 2768-2780, 2011.
143. L. A. Delouise, "Applications of nanotechnology in dermatology, " Journal of Investigative Dermatology, vol. 132, no. 3, pp. 964-975, 2012.
144. P. Scodeller, P. N. Catalano, N. Salguero, H. Duran, A. Wolosiuk, and G. J. A. A. Soler-Illia, "Hyaluronan degrading silica nanoparticles for skin cancer therapy, " Nanoscale, vol. 5, no. 20, pp. 9690-9698, 2013.
145. M. R. Prausnitz, P. M. Elias, T. J. Franz et al., "Skin barrier and transdermal drug delivery, " in Dermatology, pp. 2065-2073, Elsevier Saunders, Philadelphia, Pa, USA, 2012.
146. A. Baeza, M. Colilla, and M. Vallet-Regi, "Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery, " Expert Opinion on Drug Delivery, vol. 12, no. 2, pp. 319-337, 2015.
147. D. J. Bharali, I. Klejbor, E. K. Stachowiak et al., "Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11539-11544, 2005.
148. M. M. De Villiers, P. Aramwit, and G. S. Kwon, Nanotechnology in Drug Delivery, Science and Business Media, 2008.
149. A. Burns, H. Ow, and U. Wiesner, "Fluorescent core-shell silica nanoparticles: towards lab on a particle architectures for nanobiotechnology, " Chemical Society Reviews, vol. 35, no. 11, pp. 1028-1042, 2006.
150. W. Stober, A. Fink, and E. Bohn, "Controlled growth of monodisperse silica spheres in the micron size range, " Journal of Colloid and Interface Science, vol. 26, no. 1, pp. 62-69, 1968.
151. H. Yamauchi, T. Ishikawa, and S. Kondo, "Surface characterization of ultramicro spherical particles of silica prepared by w/o microemulsion method, " Colloids and Surfaces, vol. 37, pp. 71-80, 1989.
152. K. Osseo-Asare and F. J. Arriagada, "Preparation of SiO2 nanoparticles in a non-ionic reverse micellar system, " Colloids and Surfaces, vol. 50, pp. 321-339, 1990.
153. R. Lindberg, J. Sjoblom, and G. Sundholm, "Preparation of silica particles utilizing the sol-gel and the emulsion-gel processes, " Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 99, no. 1, pp. 79-88, 1995.
154. L. Accomasso, E. C. Rocchietti, S. Raimondo et al., "Fluorescent silica nanoparticles improve optical imaging of stem cells allowing direct discrimination between live and early-stage apoptotic cells, " Small, vol. 8, no. 20, pp. 3192-3200, 2012.
155. A. Lesniak, F. Fenaroli, M. P. Monopoli, C. Aberg, K. A. Dawson, and A. Salvati, "Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells, " ACS Nano, vol. 6, no. 7, pp. 5845-5857, 2012.
156. F. Catalano, L. Accomasso, G. Alberto et al., "Factors ruling the uptake of silica nanoparticles by mesenchymal stem cells: agglomeration versus dispersions, absence versus presence of serum proteins, " Small, vol. 11, no. 24, pp. 2919-2928, 2015.
157. D.-M. Huang, Y. Hung, B.-S. Ko et al., "Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking, " The FASEB Journal, vol. 19, no. 14, pp. 2014-2016, 2005.
158. T.-H. Chung, S.-H. Wu, M. Yao et al., "The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells, " Biomaterials, vol. 28, no. 19, pp. 2959-2966, 2007.
159. D.-M. Huang, T.-H. Chung, Y. Hung et al., "Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stemcells, " Toxicology and Applied Pharmacology, vol. 231, no. 2, pp. 208-215, 2008.
160. S. Wei, Q. Wang, J. Zhu, L. Sun, H. Lin, and Z. Guo, "Multifunctional composite core-shell nanoparticles, " Nanoscale, vol. 3, no. 11, pp. 4474-4502, 2011.
161. H.-M. Liu, S.-H. Wu, C.-W. Lu et al., "Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells, " Small, vol. 4, no. 5, pp. 619-626, 2008.
162. L. Zhang, Y. Wang, Y. Tang et al., "High MRI performance fluorescent mesoporous silica-coated magnetic nanoparticles for tracking neural progenitor cells in an ischemic mouse model, " Nanoscale, vol. 5, no. 10, pp. 4506-4516, 2013.
163. A. Liberman, H. P. Martinez, C. N. Ta et al., "Hollow silica and silica-boron nano/microparticles for contrast-enhanced ultrasound to detect small tumors, " Biomaterials, vol. 33, no. 20, pp. 5124-5129, 2012.
164. Y.-S. Chen, W. Frey, S. Kim, P. Kruizinga, K. Homan, and S. Emelianov, "Silica-coated gold nanorods as photoacoustic signal nano-amplifiers, " Nano Letters, vol. 11, no. 2, pp. 348-354, 2011.
165. J. P. Rao and K. E. Geckeler, "Polymer nanoparticles: preparation techniques and size-control parameters, " Progress in Polymer Science, vol. 36, no. 7, pp. 887-913, 2011.
166. E. Abbasi, S. F. Aval, A. Akbarzadeh et al., "Dendrimers: synthesis, applications, and properties, " Nanoscale Research Letters, vol. 9, no. 1, pp. 1-10, 2014.
167. H. N. Patel and P. M. Patel, "Dendrimer applications-a review, " International Journal of Pharma and Bio Sciences, vol. 4, no. 2, pp. 454-463, 2013.
168. R. M. Kannan, E. Nance, S. Kannan, and D. A. Tomalia, "Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications, " Journal of Internal Medicine, vol. 276, no. 6, pp. 579-617, 2014.
169. M. Jedrych, K. Borowska, R. Galus, and B. Jodlowska-Jedrych, "The evaluation of the biomedical effectiveness of poly(amido)amine dendrimers generation 4. 0 as a drug and as drug carriers: a systematic review and meta-analysis, " International Journal of Pharmaceutics, vol. 462, no. 1-2, pp. 38-43, 2014.
170. D. Bennet and S. Kim, "Polymer nanoparticles for smart drug delivery, " in Application of Nanotechnology in Drug Delivery, A. D. Sezer, Ed., chapter 8, InTech, Rijeka, Croatia, 2014.
171. S. B. Brijmohan, S. Swier, R. A. Weiss, and M. T. Shaw, "Synthesis and characterization of cross-linked sulfonated polystyrene nanoparticles, " Industrial and Engineering Chemistry Research, vol. 44, no. 21, pp. 8039-8045, 2005.
172. X. Jiang, J. Dausend, M. Hafner et al., "Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells, " Biomacromolecules, vol. 11, no. 3, pp. 748-753, 2010.
173. M. C. Baier, J. Huber, and S. Mecking, "Fluorescent conjugated polymer nanoparticles by polymerization in miniemulsion, " Journal of the American Chemical Society, vol. 131, no. 40, pp. 14267-14273, 2009.
174. L. Fang, Y. Li, R. Wang, C. Xu, and S. Li, "Synthesis and photophysical properties of poly(aryleneethynylene)s bearing dialkylsilyl side substituents, " European Polymer Journal, vol. 45, no. 4, pp. 1092-1097, 2009.
175. R. Wang, C. Zhang, W. Wang, and T. Liu, "Preparation, morphology, and biolabeling of fluorescent nanoparticles based on conjugated polymers by emulsion polymerization, " Journal of Polymer Science A: Polymer Chemistry, vol. 48, no. 21, pp. 4867-4874, 2010.
176. Y. Liu, R. C. Mills, J. M. Boncella, and K. S. Schanze, "Fluorescent polyacetylene thin film sensor for nitroaromatics, " Langmuir, vol. 17, no. 24, pp. 7452-7455, 2001.
177. F. Wang, W. B. Tan, Y. Zhang, X. Fan, and M. Wang, "Luminescent nanomaterials for biological labelling, "Nanotechnology, vol. 17, no. 1, p. R1, 2006.
178. S. Huang, S. Liu, K. Wang et al., "Highly fluorescent and bioresorbable polymeric nanoparticles with enhanced photostability for cell imaging, " Nanoscale, vol. 7, no. 3, pp. 889-895, 2015.
179. R. Francis, N. Joy, E. P. Aparna, and R. Vijayan, "Polymer grafted inorganic nanoparticles, preparation, properties, and applications: a review, " Polymer Reviews, vol. 54, no. 2, pp. 268-347, 2014.
180. Y.-X. J. Wang, S. M. Hussain, and G. P. Krestin, "Superparamagnetic iron oxide contrast agents: physicochemical characteristics andapplications inMR imaging, " European Radiology, vol. 11, no. 11, pp. 2319-2331, 2001.
181. C. Xu, L. Mu, I. Roes et al., "Nanoparticle-basedmonitoring of cell therapy, " Nanotechnology, vol. 22, no. 49, Article ID494001, 2011.
182. A. K. Gupta and M. Gupta, "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications, " Biomaterials, vol. 26, no. 18, pp. 3995-4021, 2005.
183. L.-S. Wang, M.-C. Chuang, and J.-A. A. Ho, "Nanotheranostics- a review of recent publications, " International Journal of Nanomedicine, vol. 7, pp. 4679-4695, 2012.
184. J. Ovrevik, R. B. Hetland, R. P. Schins, T. Myran, and P. E. Schwarze, "Iron release and ROS generation from mineral particles are not related to cytokine release or apoptosis in exposed A549 cells, " Toxicology Letters, vol. 165, no. 1, pp. 31-38, 2006.
185. P. L. Apopa, Y. Qian, R. Shao et al., "Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling, " Particle and Fibre Toxicology, vol. 6, no. 1, article 1, 2009.
186. N. Lee and T. Hyeon, "Designed synthesis of uniformly sized iron oxide nanoparticles for efficientmagnetic resonance imaging contrast agents, " Chemical Society Reviews, vol. 41, no. 7, pp. 2575-2589, 2012.
187. Y.-X. J. Wang, "Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application, " Quantitative Imaging in Medicine and Surgery, vol. 1, no. 1, pp. 35-40, 2011.
188. M. Zhao, M. F. Kircher, L. Josephson, and R. Weissleder, "Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake, " Bioconjugate Chemistry, vol. 13, no. 4, pp. 840-844, 2002.
189. A. S. Arbab, G. T. Yocum, L. B. Wilson et al., "Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability, "Molecular Imaging, vol. 3, no. 1, pp. 24-32, 2004.
190. T. Arai, T. Kofidis, J. W. M. Bulte et al., "Dual in vivo magnetic resonance evaluation ofmagnetically labeled mouse embryonic stem cells and cardiac function at 1. 5 t, " Magnetic Resonance in Medicine, vol. 55, no. 1, pp. 203-209, 2006.
191. A. Stroh, C. Faber, T. Neuberger et al., "In vivo detection limits of magnetically labeled embryonic stem cells in the rat brain using high-field (17. 6 T) magnetic resonance imaging, " NeuroImage, vol. 24, no. 3, pp. 635-645, 2005.
192. E. Sykova and P. Jendelova, "Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord, " Annals of the New York Academy of Sciences, vol. 1049, no. 1, pp. 146-160, 2005.
193. J.-K. Hsiao, M.-F. Tai, H.-H. Chu et al., "Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1. 5 T magnetic resonance at the single cell level, "Magnetic Resonance in Medicine, vol. 58, no. 4, pp. 717-724, 2007.
194. C.-W. Lu, Y. Hung, J.-K. Hsiao et al., "Bifunctionalmagnetic silica nanoparticles for highly efficient human stem cell labeling, " Nano Letters, vol. 7, no. 1, pp. 149-154, 2007.
195. J. W. M. Bulte, T. Douglas, B. Witwer et al., "Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells, " Nature Biotechnology, vol. 19, no. 12, pp. 1141-1147, 2001.
196. R. Guzman, N. Uchida, T. M. Bliss et al., "Long-termmonitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 24, pp. 10211-10216, 2007.
197. F. H. Wang, I. H. Lee, N. Holmstrom et al., "Magnetic resonance tracking of nanoparticle labelled neural stem cells in a rats spinal cord, " Nanotechnology, vol. 17, no. 8, article 1911, 2006.
198. G. J.-R. Delcroix, M. Jacquart, L. Lemaire et al., "Mesenchymal andneural stemcells labeledwithHEDP-coatedSPIOnanoparticles: in vitro characterization and migration potential in rat brain, " Brain Research, vol. 1255, pp. 18-31, 2009.
199. A. Heymer, D. Haddad, M. Weber et al., "Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair, " Biomaterials, vol. 29, no. 10, pp. 1473-1483, 2008.
200. X.-H. Jing, L. Yang, X.-J. Duan et al., "InvivoMRimaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection, " Joint Bone Spine, vol. 75, no. 4, pp. 432-438, 2008.
201. L. Wang, J. Deng, J. Wang et al., "Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells, " Magnetic Resonance Imaging, vol. 27, no. 1, pp. 108-119, 2009.
202. J. W. M. Bulte, D. L. Kraitchman, A. M. Mackay et al., "Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides, " Blood, vol. 104, no. 10, pp. 3410-3413, 2004.
203. A. S. Arbab, L. B. Wilson, P. Ashari, E. K. Jordan, B. K. Lewis, and J. A. Frank, "A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging, " NMR in Biomedicine, vol. 18, no. 6, pp. 383-389, 2005.
204. Y. S. Song and J. H. Ku, "Monitoring transplanted human mesenchymal stem cells in rat and rabbit bladders using molecular magnetic resonance imaging, " Neurourology and Urodynamics, vol. 26, no. 4, pp. 584-593, 2007.
205. K.-W. Au, S.-Y. Liao, Y.-K. Lee et al., "Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells, " Biochemical and Biophysical Research Communications, vol. 379, no. 4, pp. 898-903, 2009.
206. M. Ramos-Gomez, E. G. Seiz, and A. Martinez-Serrano, "Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain, " Journal of Nanobiotechnology, vol. 13, no. 20, 2015.
207. P. K. Jain, K. S. Lee, I. H. El-Sayed, and M. A. El-Sayed, "Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine, " The Journal of Physical Chemistry B, vol. 110, no. 14, pp. 7238-7248, 2006.
208. L. Tong, Q. Wei, A. Wei, and J.-X. Cheng, "Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects, " Photochemistry and Photobiology, vol. 85, no. 1, pp. 21-32, 2009.
209. L. M. Ricles, S. Y. Nam, K. Sokolov, S. Y. Emelianov, and L. J. Suggs, "Function of mesenchymal stem cells following loading of gold nanotracers, " International Journal ofNanomedicine, vol. 6, pp. 407-416, 2011.
210. S. Y. Nam, L. M. Ricles, L. J. Suggs, and S. Y. Emelianov, "In vivo ultrasound and photoacousticmonitoring ofmesenchymal stem cells labeled with gold nanotracers, " PLoS ONE, vol. 7, no. 5, Article ID e37267, 2012.
211. J. V. Jokerst, M. Thangaraj, P. J. Kempen, R. Sinclair, and S. S. Gambhir, "Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods, " ACS Nano, vol. 6, no. 7, pp. 5920-5930, 2012.
212. S. Y. Nam, E. Chung, L. J. Suggs, and S. Y. Emelianov, "Combined ultrasound and photoacoustic imaging to noninvasively assess burn injury and selectively monitor a regenerative tissueengineered construct, " Tissue Engineering Part C: Methods, vol. 21, no. 6, pp. 557-566, 2015.
213. M. Edmundson, N. T. K. Thanh, and B. Song, "Nanoparticles based stemcell tracking in regenerativemedicine, "Theranostics, vol. 3, no. 8, pp. 573-582, 2013.
214. J. R. Slotkin, L. Chakrabarti, N. D. Hai et al., "In vivo quantum dot labeling ofmammalian stemand progenitor cells, " Developmental Dynamics, vol. 236, no. 12, pp. 3393-3401, 2007.
215. A. B. Rosen, D. J. Kelly, A. J. T. Schuldt et al., "Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis, " Stem Cells, vol. 25, no. 8, pp. 2128-2138, 2007.
216. J. M. Barnett, J. S. Penn, and A. Jayagopal, "Imaging of endothelial progenitor cell subpopulations in angiogenesis using quantum dot nanocrystals, " Methods in Molecular Biology, vol. 1026, pp. 45-56, 2013.
217. A. M. Smith, M. C. Mancini, and S. Nie, "Bioimaging: second window for in vivo imaging, " Nature Nanotechnology, vol. 4, no. 11, pp. 710-711, 2009.
218. J. Tang, J. Wang, L. Guo et al., "Mesenchymal stem cells modified with stromal cell-derived factor 1α improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a ratmodel ofmyocardial infarction, "Molecules and Cells, vol. 29, no. 1, pp. 9-19, 2010.
219. T. Schroeder, "Imaging stem-cell-driven regeneration in mammals, " Nature, vol. 453, no. 7193, pp. 345-351, 2008.
220. S. Sinha and U. Sinha, "Recent advances in breast MRI and MRS, " NMR in Biomedicine, vol. 22, no. 1, pp. 3-16, 2009.
221. N. K. Logothetis, "What we can do and what we cannot do with fMRI, " Nature, vol. 453, no. 7197, pp. 869-878, 2008.
222. P. Reimer and T. Balzer, "Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrastenhanced MRI of the liver: properties, clinical development, and applications, " European Radiology, vol. 13, no. 6, pp. 1266-1276, 2003.
223. C.-H. Lai, T.-C. Yen, and K.-K. Ng, "Molecular imaging in the management of cervical cancer, " Journal of the Formosan Medical Association, vol. 111, no. 8, pp. 412-420, 2012.
224. H. B. Na, I. C. Song, and T. Hyeon, "Inorganic nanoparticles for MRI contrast agents, " Advanced Materials, vol. 21, no. 21, pp. 2133-2148, 2009.
225. M. Lewin, N. Carlesso, C.-H. Tung et al., "Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, " Nature Biotechnology, vol. 18, no. 4, pp. 410-414, 2000.
226. L. Li, W. Jiang, K. Luo et al., "Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking, " Theranostics, vol. 3, no. 8, pp. 595-615, 2013.
227. A. E. Merbach and E. Toth, The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, vol. 46, Wiley, 2001.
228. J. S. Weinstein, C. G. Varallyay, E. Dosa et al., "Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review, " Journal of Cerebral Blood FlowandMetabolism, vol. 30, no. 1, pp. 15-35, 2010.
229. J. W. M. Bulte, I. D. Duncan, and J. A. Frank, "In vivomagnetic resonance tracking ofmagnetically labeled cells after transplantation, " Journal of Cerebral BloodFlow and Metabolism, vol. 22, no. 8, pp. 899-907, 2002.
230. S.-L. Hu, P.-G. Lu, L.-J. Zhang et al., "In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells, " Journal of Cellular Biochemistry, vol. 113, no. 3, pp. 1005-1012, 2012.
231. Y. Amsalem, Y. Mardor, M. S. Feinberg et al., "Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium, " Circulation, vol. 116, no. 11, pp. I38-I45, 2007.
232. C. Chapon, J. S. Jackson, E. O. Aboagye, A. H. Herlihy, W. A. Jones, and K. K. Bhakoo, "An in vivomultimodal imaging study using MRI and pet of stem cell transplantation aftermyocardial infarction in rats, " Molecular Imaging and Biology, vol. 11, no. 1, pp. 31-38, 2009.
233. A. Blocki, S. Beyer, J. Dewavrin et al., "Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium, " Biomaterials, vol. 53, pp. 12-24, 2015.
234. T. H. Kim, J. K. Kim, W. Shim, S. Y. Kim, T. J. Park, and J. Y. Jung, "Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI, " Magnetic Resonance Imaging, vol. 28, no. 7, pp. 1004-1013, 2010.
235. S. C. Berman, C. Galpoththawela, A. A. Gilad, J. W. M. Bulte, and P. Walczak, "Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells, " Magnetic Resonance in Medicine, vol. 65, no. 2, pp. 564-574, 2011.
236. J. Terrovitis, M. Stuber, A. Youssef et al., "Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart, " Circulation, vol. 117, no. 12, pp. 1555-1562, 2008.
237. M. Janowski, P. Walczak, T. Kropiwnicki et al., "Long-termMRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF, " PLoS ONE, vol. 9, no. 2, Article ID e97631, 2014.
238. U. Himmelreich, R. Weber, P. Ramos-Cabrer et al., "Improved stem cell MR detectability in animal models by modification of the inhalation gas, "Molecular Imaging, vol. 4, no. 2, pp. 104-109, 2005.
239. U. Himmelreich and T. Dresselaers, "Cell labeling and tracking for experimental models using magnetic resonance imaging, " Methods, vol. 48, no. 2, pp. 112-124, 2009.
240. J. Ruiz-Cabello, P. Walczak, D. A. Kedziorek et al., "In vivo hot spot MR imaging of neural stem cells using fluorinated nanoparticles, " Magnetic Resonance in Medicine, vol. 60, no. 6, pp. 1506-1511, 2008.
241. E. T. Ahrens, B. M. Helfer, C. F. O'Hanlon, and C. Schirda, "Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI, " Magnetic Resonance in Medicine, vol. 72, no. 6, pp. 1696-1701, 2014.
242. D. K. Kadayakkara, K. Damodaran, T. K. Hitchens, J. W. M. Bulte, and E. T. Ahrens, "19F spin-lattice relaxation of perfluoropolyethers: dependence on temperature and magnetic field strength (7. 0-14. 1 T), " Journal of Magnetic Resonance, vol. 242, pp. 18-22, 2014.
243. J. Ruiz-Cabello, B. P. Barnett, P. A. Bottomley, and J. W. M. Bulte, "Fluorine (19F) MRS and MRI in biomedicine, " NMR in Biomedicine, vol. 24, no. 2, pp. 114-129, 2011.
244. P. Boehm-Sturm, L. Mengler, S. Wecker, M. Hoehn, and T. Kallur, "In vivo tracking of human neural stem cells with 19F magnetic resonance imaging, " PLoS ONE, vol. 6, no. 12, Article ID e29040, 2011.
245. M. Xu and L. V. Wang, "Photoacoustic imaging in biomedicine, " Review of Scientific Instruments, vol. 77, no. 4, Article ID041101, 2006.
246. A. De La Zerda, C. Zavaleta, S. Keren et al., "Carbon nanotubes as photoacoustic molecular imaging agents in living mice, " Nature Nanotechnology, vol. 3, no. 9, pp. 557-562, 2008.
247. A. D. L. Zerda, Z. Liu, S. Bodapati et al., "Ultrahigh sensitivity carbon nanotube agents for photoacoustic molecular imaging in living mice, " Nano Letters, vol. 10, no. 6, pp. 2168-2172, 2010.
248. L. M. Ricles, S. Y. Nam, E. A. Trevino, S. Y. Emelianov, and L. J. Suggs, "A dual gold nanoparticle system for mesenchymal stem cell tracking, " Journal of Materials Chemistry B, vol. 2, no. 46, pp. 8220-8230, 2014.